N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT00093353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diarrhea
Drug/Agent Toxicity by Tissue/Organ
Neuroblastoma

Interventions

DRUG: cefixime
DRUG: irinotecan hydrochloride
DRUG: temozolomide

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]